Galmed Pharmaceuticals
GLMD
$0.40
Share price
10.68%
Change (1 day)
25.00%
Change (1 year)
Categories
Operating Margin for Galmed Pharmaceuticals (GLMD)
Operating Margin as of April 2024 (TTM): -479.93%
According to Galmed Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -479.93%. At the end of 2018 the company had an Operating Margin of -479.93%.
Operating Margin history for Galmed Pharmaceuticals from 2017 to 2018
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2018 | -479.93% | -57.66% |
| 2017 | -1,133.55% | -68.58% |
| 2016 | -3,607.49% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Evoke Pharma
EVOK | -307.90% | -35.84% | 🇺🇸 USA |
 Endo International
ENDPQ | -129.15% | -73.09% | 🇮🇪 Ireland |
 Aerie Pharmaceuticals AERI | -10.86% | -97.74% | 🇺🇸 USA |
 Catalent CTLT | 4.60% | -100.96% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.